Microinjection of D-2-amino-7-phosphonoheptanoate into the dorsal periaqueductal gray matter reduces the pressor response to glutamate injected at the same site.
The current study assesses the influence of the N-methyl-D-aspartate (NMDA) receptor antagonist D-2-amino-7-phosphonoheptanoate (AP7) on the pressor effect of glutamate microinjected into the dorsal periaqueductal gray matter (DPAG) of urethane-anesthetized rats. Glutamate (20, 40 and 80 nmol/site) caused dose-related reproducible increases in systolic and diastolic blood pressure. Microinjection of saline into the DPAG did not alter the pressor effects of glutamate (80 nmol/site). Similar pretreatment with AP7 (2 nmol/site) significantly (P less than 0.05) attenuated the pressor effects of glutamate from +26.5 +/- 7.0 to +3.4 +/- 3.3 mmHg (systolic blood pressure). We conclude that the pressor effect of glutamate in the DPAG is mediated largely by activation of NMDA receptors.